Operating Lease, Right-of-Use Asset of Tevogen Bio Holdings Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tevogen Bio Holdings Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Tevogen Bio Holdings Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,451,198, a 398% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tevogen Bio Holdings Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,451,198 +$1,159,713 +398% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $1,477,905 +$1,125,232 +319% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $163,641 -$248,470 -60% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $228,490 -$241,372 -51% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $291,485 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 $352,673 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $412,111 31 Mar 2024 10-Q 28 May 2024 2024 Q1
Q4 2023 $469,862 31 Dec 2023 10-K 02 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.